No insider purchase over the last 90 days. The latest, by Anonymous (PDMR), was filed 18 May 2026.
Every trade that managers of Synthaverse SA disclose to KNF is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 24 October 2026, 17 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 3 purchases totalling €60k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 senior executive. The largest single trade was a purchase of €29k, published on 18 May 2026.
The latest purchase dates back some time: it was published 158 days ago, on 18 May 2026.
For context, the typical company on the same exchange (median of 216 companies) published 4 filings over the same period, against 17 filings here. Since 2025, the database holds 3 purchases and no sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by KNF. They describe what insiders did and are not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
17 of 17 declarations
Synthaverse SA is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XWAR market.
Purchases our model currently ranks for the recommendations list.
All recommendations